About Us
History
RRD was founded in 2002 to create an alternative approach to drug development, enabling more efficient use of capital and accelerating asset value whether it be human proof-of-concept (hPOC), or marketing approval.
Our Product Development Team (PDT) partnering model has a long track record of value creation by defining the right strategy and controlling operational execution for more predictable achievement of value.
Our expertise and experience spans the entire drug development process and combines rigorous scientific input, strategic insight, program management, and operational excellence to more rapidly achieve development milestones.
In 2020, RRD was acquired by Uniphar, a global diversified healthcare services company. The acquisition has enabled RRD to accelerate its growth through investment in its core development model as well as new capabilities that broaden RRD’s service offerings to its product development partners.
About Uniphar
Uniphar is a trusted global partner to pharma, medtech and biotech, delivering solutions that connect medicines and technologies with patients worldwide. With over 57 years of experience and partnerships with 200+ multinational clients, Uniphar combines deep expertise, global infrastructure and market insight to meet the evolving needs of the life sciences sector.
Uniphar Pharma integrates Development, Clinical, Access, Medical, Commercial, Distribution and Global Sourcing to support the full product lifecycle – from early-stage research through to commercialization and beyond. Uniphar’s unified platform spans regulatory strategy, clinical trial support, medical affairs, market access, patient engagement, commercial services, distribution and supply chain.
Operating across 180 countries with a global team of 3,500+, Uniphar bridges manufacturers, healthcare providers, and patients — accelerating access to innovative therapies, improving patient outcomes, and delivering value across the healthcare ecosystem.
From molecule to market and beyond.
For more information, visit Uniphar and Uniphar US.
